504 related articles for article (PubMed ID: 15896881)
1. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
3. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Brüss M; Bönisch H; Bühlen M; Nöthen MM; Propping P; Göthert M
Pharmacogenetics; 1999 Feb; 9(1):95-102. PubMed ID: 10208648
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
[TBL] [Abstract][Full Text] [Related]
5. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
[TBL] [Abstract][Full Text] [Related]
7. Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor.
Kiel S; Bönisch H; Brüss M; Göthert M
Pharmacogenetics; 2003 Feb; 13(2):119-26. PubMed ID: 12563181
[TBL] [Abstract][Full Text] [Related]
8. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
9. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
Krobert KA; Levy FO
Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
[TBL] [Abstract][Full Text] [Related]
10. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
11. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
[TBL] [Abstract][Full Text] [Related]
13. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
14. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
[TBL] [Abstract][Full Text] [Related]
15. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
16. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Plassat JL; Amlaiky N; Hen R
Mol Pharmacol; 1993 Aug; 44(2):229-36. PubMed ID: 8394987
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
[TBL] [Abstract][Full Text] [Related]
20. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]